Mukka Proteins Q1 FY27: Strong export-led quarter, with sustainability and diversification moving to the centre

Mukka Proteins Limited presented a sharp step-up in scale in Q1 FY27, backed by export demand and favourable fish meal pricing. Consolidated revenue from operations rose to INR 489.7 crore, compared with INR 170.8 crore in Q1 FY26 and INR 380.6 crore in Q4 FY26. Profitability remained positive but showed quarter-on-quarter compression. EBITDA came in at INR 48.6 crore with a 9.9% margin, while PAT stood at INR 18.6 crore with a 3.8% margin.

The company’s pitch to investors is no longer limited to fishmeal and fish oil. The presentation positions Mukka Proteins as an integrated animal protein and sustainability platform spanning fish protein, alternate proteins using Black Soldier Fly biotechnology, waste management and environmental solutions, and frozen plus value-added seafood. Export markets continue to anchor the model. The company reported an 89.5% export revenue share in Q1 FY27 and a presence across 25+ countries.

Q1 FY27 performance: revenue expands faster than margins

The quarter’s revenue expansion is clear in the presentation’s consolidated trend chart. The company attributes the performance to strong demand across domestic and export markets, supported by favourable fish meal pricing and improved realizations. However, margins in Q1 FY27 were lower than Q4 FY26, even though absolute EBITDA stayed close. Q4 FY26 EBITDA margin was shown at 12.9% versus 9.9% in Q1 FY27, and PAT margin was 5.6% versus 3.8%.

While the investor deck does not provide segment-wise revenue or margin break-up, it does offer annual financials that show the business is large and working capital intensive by nature. Revenues from operations in FY26 were INR 1,403.6 crore, and total revenues from operations were INR 1,449.5 crore. Finance costs have moved up over time, reaching INR 53.6 crore in FY26 versus INR 37.3 crore in FY25.

Strategy lens: from fishmeal to a multi-vertical platform

Mukka Proteins frames its evolution as a shift from fishmeal to an integrated platform combining proteins and sustainability. The operating model is built around four verticals.

Fish protein remains the core, comprising fish meal, fish oil, and fish soluble paste. The presentation claims a 25 to 30% market share in revenue generated from fish meal and fish oil, and highlights high protein consistency in fishmeal at 60 to 65% protein content. It also provides end-use concentration for fishmeal, led by aquaculture at 91%, with smaller contributions from poultry, swine, and other uses.

Fish oil is presented as an omega-3 rich by-product with diversified end uses. The deck shows a usage split: 63% aquaculture, 16% omega-3 supplements, and 21% other uses such as biofuel, swine feed, pet food, and cooking oil. Fish soluble paste is described as a value-added output from stick water evaporation with 40 to 50% moisture and around 40% protein content, supporting a zero-waste manufacturing narrative.

The second pillar is alternate proteins using Black Soldier Fly biotechnology. Here, the company positions itself as a pioneer in India’s BSF-based insect protein and compost industry, converting municipal wet waste into insect meal, insect oil, insect compost, humic acid, and briquettes. Capacity numbers are provided for this vertical: 200 TPD in Mangaluru, 1,000 TPD in Bengaluru, and 200 TPD in Kochi.

The third pillar is waste management and environmental solutions. The flagship project discussed is the Bengaluru leachate treatment project for Bengaluru Solid Waste Management Ltd. The presentation states an order value of INR 474.89 crore ex-GST, capex of about INR 100 crore, a build timeline of around six months, and a total project tenure of four years. Mukka’s JV stake is stated at 76%. The company also links this platform to potential upside from carbon credits, noting approvals for 1,200 TPD.

The fourth pillar is frozen and value-added marine products, positioned as forward integration to diversify margins and monetise raw material better. The presentation highlights EU-approved processing capability through Ocean Proteins and Meli, Mukka Frozen Impex. It provides combined capacity numbers: total freezing capacity of 167 TPD and cold storage capacity of 1,926 TPD.

Expansion and risk management: acquisitions, certifications, and litigation closure

The quarter’s corporate actions underline a continuing inorganic growth approach. In Q1 FY27, the company highlighted the acquisition of a 51% stake in Delta Marine Products for INR 11.1 crore to strengthen fish meal and fish oil manufacturing capability. It also approved an acquisition of 51% stake in Aqua Marine for up to INR 15 crore, positioned as a capacity and efficiency move. On the sustainability side, the company approved an investment of INR 64.9 lakh for a 25.98% stake in Swachha Eco Solutions to expand in waste-to-valor and environmental solutions.

A notable de-risking event in the quarter was the resolution of a customs litigation matter. The presentation states that the Hon’ble CESTAT set aside the entire demand of approximately INR 15.2 crore, along with associated interest and penalties. This reduces regulatory overhang and improves visibility.

The export-facing nature of the business makes certifications and sourcing credibility important. Mukka highlights its acceptance under the MarinTrust Improver Programme, with confirmation from Global Trust Certification (NSF), Ireland. The deck describes this as improving supply chain transparency, ensuring compliance readiness for standards such as BAP, ASC, and Global G.A.P., and reducing sourcing risks via traceable, FIP-linked supply chains.

On manufacturing and supply chain, the presentation stresses a coastal asset strategy with Oman as a key advantage due to proximity to GCC and export markets and access to high-quality raw material. It also discusses an upcoming facility at Aljoubah Industrial Area in Oman, spread over 21,249 sq. meters, expected to commence operations in the coming quarters.

What to track next

The presentation lays out an explicit revenue growth outlook. It cites FY26 revenue at INR 1,449 crore and targets INR 3,000+ crore by FY30, implying more than 2x growth in about four years. The strategic levers are clear: scale in fish protein exports, broader product monetisation, growth in alternate proteins, and replication of waste management projects.

At the same time, investors will need to track how the company balances growth with margin stability, especially given quarter-on-quarter volatility shown between Q4 FY26 and Q1 FY27. The annual table also shows rising finance costs, which makes capital allocation and execution efficiency important.

The near-term narrative is anchored by three concrete items in the presentation: sustained export strength with 89.5% export revenue share in Q1 FY27, the Bengaluru leachate project with a four-year tenure, and ongoing capacity expansion through acquisitions and the upcoming Oman facility. If these translate into visible, repeatable cash flows and stable returns, the diversified platform thesis becomes easier to validate.